6.64
4.40%
0.28
前日終値:
$6.36
開ける:
$6.46
24時間の取引高:
578.29K
Relative Volume:
0.42
時価総額:
$369.01M
収益:
$217.11M
当期純損益:
$-651.19M
株価収益率:
-9.3521
EPS:
-0.71
ネットキャッシュフロー:
$-387.26M
1週間 パフォーマンス:
-9.17%
1か月 パフォーマンス:
-25.56%
6か月 パフォーマンス:
-77.30%
1年 パフォーマンス:
-88.39%
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
名前
Ginkgo Bioworks Holdings Inc
セクター
電話
(877) 442-5362
住所
27 DRYDOCK AVENUE, BOSTON
DNA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
DNA | 6.65 | 369.01M | 217.11M | -651.19M | -387.26M | -0.71 |
VRTX | 450.91 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 749.43 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 589.59 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.94 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 106.93 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-05-15 | ダウングレード | BTIG Research | Neutral → Sell |
2024-05-10 | ダウングレード | William Blair | Mkt Perform → Underperform |
2023-11-14 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2023-11-09 | ダウングレード | BTIG Research | Buy → Neutral |
2023-06-02 | ダウングレード | Goldman | Neutral → Sell |
2023-05-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
2022-11-29 | 開始されました | Berenberg | Buy |
2022-10-04 | 開始されました | Morgan Stanley | Equal-Weight |
2022-05-18 | ダウングレード | BofA Securities | Neutral → Underperform |
2022-03-02 | 再開されました | Cowen | Outperform |
2022-02-23 | 開始されました | Goldman | Neutral |
2022-02-01 | 開始されました | BofA Securities | Neutral |
2022-01-28 | 開始されました | BofA Securities | Buy |
2022-01-07 | 開始されました | BTIG Research | Buy |
2021-11-29 | 開始されました | Jefferies | Buy |
2021-10-13 | 開始されました | Raymond James | Outperform |
2021-10-12 | 開始されました | William Blair | Outperform |
2021-09-20 | 開始されました | HSBC Securities | Buy |
すべてを表示
Ginkgo Bioworks Holdings Inc (DNA) 最新ニュース
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Tao Capital Management LP - MarketBeat
US Bancorp DE Sells 183,450 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
How To Trade (DNA) - Stock Traders Daily
Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better (NYSE:DNA) - Seeking Alpha
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Short Interest Update - MarketBeat
GSA Capital Partners LLP Has $979,000 Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Simply Wall St
Ginkgo Bioworks Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Ginkgo cancels move to new South Boston lab, exits Cambridge office - MassLive.com
Ginkgo Bioworks Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q3 2024 Earnings Call Transcript - MSN
Ginkgo Bioworks: Not Enough Progress (NYSE:DNA) - Seeking Alpha
Baillie Gifford & Co. Sells 131,067,285 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Reports Q3 Growth and Strategic Deals - TipRanks
Ginkgo nixes move to South Boston lab, will exit Cambridge sites. Here's what it means - NBC Boston
Ginkgo nixes move to South Boston lab, will exit Cambridge sites - The Business Journals
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q3 Loss, Tops Revenue Estimates - MSN
Ginkgo Bioworks Reports Third Quarter 2024 Financial Results – Company Announcement - Financial Times
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing - Marketscreener.com
Ginkgo Bioworks Secures $9M Milestone Payment from Merck Partnership Breakthrough | DNA Stock News - StockTitan
Insights into Ginkgo Bioworks Holdings's Upcoming Earnings - Benzinga
Ginkgo Bioworks chief accounting officer sells $2,522 in stock - Investing.com India
Ginkgo Bioworks chief accounting officer sells $2,522 in stock By Investing.com - Investing.com Australia
(DNA) On The My Stocks Page - Stock Traders Daily
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat
Ginkgo Bioworks (DNA) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
BTIG Downgrades Ginkgo Bioworks Holdings Inc(DNA) - MSN
Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market - MSN
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation - BioSpace
Ginkgo Bioworks (DNA) Sets Q3 2024 Earnings Call for November 12 | DNA Stock News - StockTitan
Dutch ingredients Firm Vivici Partners With Ginkgo Bioworks For Alternative Protein Development - MSN
Vanguard Group Inc's Strategic Reduction in Ginkgo Bioworks Holdings Inc - GuruFocus.com
With 48% ownership, Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has piqued the interest of institutional investors - Yahoo Finance
Ginkgo Bioworks (DNA): A Leader in Cell Programming and Genetic Diagnostics - Insider Monkey
10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey
Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know - MSN
Forbes J M & Co. LLP Invests $1.02 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
PFG Investments LLC Invests $1.54 Million in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Major Boston biotech company begins layoffs this week - MSN
Ginkgo Bioworks (NYSE:DNA) Shares Up 5%Here's What Happened - MarketBeat
Equitec Proprietary Markets LLC Has $99,000 Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Sees Significant Growth in Short Interest - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Trading 5.9% HigherStill a Buy? - MarketBeat
Exchange Traded Concepts LLC Has $2.99 Million Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now? - MSN
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Squarepoint Ops LLC - MarketBeat
Algert Global LLC Takes $36,000 Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Receives $4.16 Consensus Target Price from Analysts - MarketBeat
Ginkgo Bioworks Holdings Inc (DNA) Q2 2024 Earnings Call Highlights: Strategic Restructuring ... By GuruFocus - Investing.com Canada
Ginkgo Bioworks executive sells over $10k in company stock By Investing.com - Investing.com Australia
Ginkgo Bioworks exec sells over $2500 in stock By Investing.com - Investing.com Canada
Ginkgo Bioworks Holdings Inc (DNA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):